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generating hypotheses about causality: evidence
from 36 years of population-based follow-up
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Background: Celiac disease (CD) is a major public health problem with estimated 1-3% prevalence in the general
population. In recent years an increase in CD prevalence has been reported both in Sweden and worldwide. This
study aimed at examining the annual incidence rate of biopsy-proven celiac disease among children in Sweden
over a 36-year period, to assess variations by age, sex and birth cohort, and to assess the clinical impact of
these changes.
Methods: The National Swedish Childhood CD Register was used to identify 9107 children aged 0–14.9 years who
were diagnosed with CD during the period 1973 to 2009. From 1973 to 1990 the register covered 15% of the
nation, this increased to 40% during 1991–1997; a full national coverage was obtained from 1998 onwards.
Estimations for the annual incidence rate, cumulative incidence and clinical impact by age groups, calendar month
and birth cohorts were made.
Results: CD incidence is continuing to increase in the child population aged 2–14.9 years. A continued variation in
CD incidence was observed in children aged 0–1.9 years, characterized by a marked decrease in most recent years.
The median age at diagnosis has increased from 1.0 year in the 1970s to 6.8 years in 2009. The average number of
new cases has risen from ~200 during 1973–1983 to ~600 during 2004–2009. In the birth cohorts of 2000–2002 the
cumulative incidence even exceeded that of the epidemic cohorts at comparable ages. The highest cumulative
incidence was observed in the birth cohorts of 1985–1995 and 2000–2002.
Conclusions: CD risk varies between birth cohorts, suggesting cyclic environmental and/or lifestyle risk factors
in CD etiology. More research on underlying risk factors is required in order to move forward with preventive
strategies.
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Celiac disease (CD) is a chronic small intestinal immune-
mediated enteropathy triggered by the ingestion of gluten
in genetically susceptible individuals [1]. Children with
undiagnosed CD are at risk for stunted growth, delayed
puberty, and many other health problems [2,3]. CD is
most effectively treated by life-long elimination of wheat,
rye, and barley, which results in restoration of the intes-
tinal morphology and alleviation of CD symptoms and
some associated health risks [4,5].* Correspondence: fredinah.namatovu@epiph.umu.se
1Department of Public Health and Clinical Medicine, Epidemiology and
Global Health, Umeå University, Umeå SE-901 87, Sweden
Full list of author information is available at the end of the article
© 2014 Namatovu et al.; licensee BioMed Cen
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.The National Swedish Childhood CD Register has
tracked the incidence of CD in children below 15 years
of age since 1973, revealing a CD epidemic between
1984 and 1994 among children younger than 2 years of
age [6,7]. The epidemic was explained by changes over
time in infant feeding, and by the interaction between
infant feeding and infections early in life [6-9]. The
current study aims to examine the annual incidence
rate of biopsy-confirmed CD among children in
Sweden over a 36-year period and to assess variations
by age, sex, and birth cohort as well as the clinical im-
pact of these changes.tral Ltd. This is an Open Access article distributed under the terms of the
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The National Swedish Childhood CD Register was used to
identify children from 0 to 14.9 years of age with newly di-
agnosed CD. The register was established in 1991 and is
hosted by the unit of Epidemiology and Global Health at
Umeå University, Sweden, and it currently records all new
probable CD cases identified in Sweden. Children diag-
nosed with CD between 1973 and 1990 were retrospectively
added to the register from the records of five pediatric
units, covering about 15% of the national population. From
1991 to 1997, 14 pediatric units (40% national coverage) re-
ported their cases to the register. Nationwide coverage was
attained in 1998, and all 47 pediatric clinics in Sweden now
report cases to the register. Other details regarding the
National Swedish Childhood CD Register can be found
elsewhere [6].
Celiac disease case ascertainment
CD was ascertained using the diagnostic criteria provided
by the European Society for Pediatric Gastroenterology,
Hepatology and Nutrition (ESPGHAN). Before 1990, a
CD diagnosis required three consecutive small intestinal
biopsies, the first with a normal gluten-containing diet,
the second without gluten, and the third after re-
introduction of gluten [10]. Revised diagnostic criteria,
which were launched in 1990 and fully adopted in Sweden
about 10 years later, consider villous atrophy on a normal
diet, followed by clinical remission on a gluten-free diet,
as sufficient for diagnosis [11].
Using these criteria a total of 9107 children with veri-
fied CD were identified during the period from 1973 to
2009. Of these, 2151 were diagnosed from 1973 to 1997,
and 2922 cases were identified from 1998 to 2003 [6,12].
During the last follow-up from 2004 to 2009, 4279 chil-
dren were reported to the register as suspected CD cases.
A small intestinal biopsy showing villous atrophy con-
firmed CD in 4034 of these children, and the remaining








Figure 1 Inclusion and exclusion procedure for CD cases diagnosed fPopulation data
Population data were obtained from Statistics Sweden and
were divided according to hospital catchment area, time
period, and age group. The baseline period from 1973 to
1997 consisted of 598,262 births and 8,909,501 person-
years of follow-up, the period from 1998 to 2003 had
454,923 births and 9,777,930 person-years of follow-up
[6,12] and the period from 2004 to 2009 had 524,909
births and 9,352,310 person-years of follow-up.
Statistical analysis
The occurrence of CD in children is reported as the in-
cidence rate, cumulative incidence, and clinical impact.
Annual incidence rates were calculated by dividing the
number of diagnosed new cases by the number of person-
years of follow-up, approximated by the mid-year
population, and were reported per 100,000 person-years.
Age-specific incidence rates were calculated for the age
categories 0–1.9, 2–4.9, and 5–14.9 years for the period
from 1973 to 2009 to enable comparison with previous
studies. Additional incidence rates were calculated for the
period from 1998 to 2009, with stratification by age (0, 1,
2, 3–6, 7–10, and 11–14 years), to examine recent changes
in detail. Cumulative incidence by age from 1973 to 2009
was calculated by dividing the number of cases diagnosed
up to the highest age attained by the number of newborns
in each birth cohort, and it was reported per 1000 births.
Clinical impact was defined as the annual number of new
CD cases diagnosed in the entire country, and was re-
ported for the age categories 0–1.9, 2–4.9 and 5–14.9 years
for the period from 1973 to 2009. This was estimated by
multiplying each annual age-specific incidence rate by
100,000 person-years, which reflected the average Swedish
birth cohort of 100,000 children. The statistical signifi-
cance of differences in CD incidence rates was determined
with a logistic regression model using CD as a binary
dependent variable and the year of diagnosis as an explana-




Normal mucosa (n = 44)
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Biopsy not conducted
(n = 36)
Missing data for first 
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rom 2004 to 2009.
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incidence for different birth cohorts. Microsoft Excel
2008 (version 12.3.2) and SPSS 19.0 (SPSS, Chicago, IL)
were used for all estimations.
Ethical considerations
The Research Ethics Committee of all Swedish Medical
Faculties approved the use of the National Swedish Child-
hood CD Register.
Results
Annual incidence rates from 1973 to 2009
Over the 36 years of follow-up, there has been an aver-
age annual increase in CD incidence in the child popula-
tion of 4% (Odds ratio = 1.04, p <0.001). The average
baseline incidence rate in children aged 0–14.9 years
was ~10 cases per 100,000 person-years from 1973 to
1984, and this increased to ~33 cases per 100,000 person-
years from 1985 to 1994. A temporary decline occurred
from 1995 to 1997, with an average incidence rate of 25
cases per 100,000 person-years, but the rate increased
again from 1998 to 2003 and from 2004 to 2009, reaching
31 cases per 100,000 person-years and 42 cases per
100,000 person-years, respectively (Figure 2A).
Figure 2B shows a remarkable variation over time in
the CD rate in children younger than 2 years of age. In
the 1970s, the incidence rate was about 65 cases per
100,000 person-years. The incidence rate increased sharply
in the mid 1980s, and during the period from 1985 to 1994
the average incidence rate was 189 cases per 100,000Figure 2 The annual incidence rate of CD in Swedish children from 19
The incidence rate stratified in three age groups. C) More detailed informaperson-years. This was followed by an abrupt decline start-
ing in 1995, and by 2000 the average incidence rate was
about 77 cases per 100,000 person-years. A temporary in-
crease occurred from 2001 to 2003, reaching 85 cases per
100,000 person-years, but the rate declined again during
the period from 2004 to 2009 to 48 cases per 100,000
person-years, which was the lowest rate in this age group
since surveillance was initiated.
Children aged 2–4.9 years experienced a gradual but
persistent increase over time in the incidence rate of
CD. We estimated an average incidence rate of 53 cases
per 100,000 person-years during the period from 2004
to 2009, a rate ten times higher than that observed dur-
ing the period from 1973 to 1984 (Figure 2B).
A similar pattern was seen in children aged 5–14.9 years,
but it was always at a lower level compared to the younger
age groups. Over the period from 1973 to 1984 the aver-
age incidence rate was about 1 per 100,000 person-years,
and this increased to ~ 4 cases per 100,000 person-years
from 1985 to 1994, and continued to rise to 23 cases per
100,000 person-years from 1998 to 2003 (Figure 2B). Dur-
ing the period 2004 to 2009, the mean average incidence
rate reached 38 cases per 100,000 person-years.
Age-specific annual incidence rates from 1998 to 2009
The CD incidence rate varied considerably over the
period from 1998 to 2009 for all age groups (Figure 2C).
The already low CD incidence rate among children below
one year of age decreased further to become negligible.
The highest incidence rate was always found in the age73 to 2009. A) The average incidence rate for children of all ages. B)
tion on the incidence rate for the period from 1998 to 2009.
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trend from 1998 to 2003, followed by an explicit decline
from 2004 to 2008 and a slight increase again in 2009. In
children 2–2.9 years of age, the incidence rate increased
from 1998 to 2005 and then declined, and by 2008 it had
reached a level similar to that observed in older children.
Throughout this period from 1998 to 2008, the CD in-
cidence rates in children aged 3–6.9, 7–10.9, and 11–
14.9 years were about the same and were characterized
by a slow but persistent increase over time.Clinical impact
Considering the whole period from 1973 to 2009, the
annual number of cases diagnosed increased over time
except for a temporary drop during the period 1995 to
1997 (Figure 3A). Between 1973 and 1984, ~ 200 new
cases were detected annually and almost all cases were
found in children younger than 2 years of age. In the
mid-1980s there was an abrupt increase, and the annual
number of diagnosed cases was ~500. This rate remained
high until the mid 1990s. During this period nearly all
new CD cases were still diagnosed in children less than
two years of age, but CD had also become slightly more
common in those aged 2–14.9 years (Figure 3A). From
1998 to 2009 the annual number of newly detected cases














































Figure 3 New cases and age at diagnosis. A) The estimated number of
the period from 1973 to 2009. B) The median age at CD diagnosis for childperiod the number of new cases was highest in children
aged 5–14.9 years.
Age at diagnosis
From 1973 to 1994 the median age at diagnosis, was esti-
mated at 1.1 years, interquartile range 0.8–1.5 years, and
it remained very low. Starting in 1995 the median age at
diagnosis abruptly shifted to 4.6 years (interquartile range
1.6–8.3 years). The median age at diagnosis has slowly
continued to increase up to 6.7 years (interquartile range
3.1–11.1 years) during the period 2004 to 2009.
Sex-distribution
The incidence rate of CD over the entire follow-up
period is about twice as high in girls compared to boys.
Among the newly diagnosed children (2004–2009), CD
was confirmed in 2546 girls (63%) and 1488 boys (37%).
These figures are in accordance with the sex distribution
seen in our previous studies covering the period from
1973 to 2003 [6,12].
Cumulative incidence
The epidemic birth cohorts (1984–1994) maintained the
highest cumulative incidence at comparable ages over
the entire follow-up period until 2009, and the only ex-
ceptions to this pattern were the cohorts of 2000–2002
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Figure 4 Cumulative incidence of CD for children born between 1973 and 2009 and followed from birth until 2009 or to an age of
14.9 years. To increase readability, cohorts from 1973–1997 are aggregated into three intuitive groups according to similarities in the cumulative
incidence in those periods. Each cohort from 1998 to 2008 is reported separately.
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first 2 years of age, followed by a gradual but continuous
increase up to 14 years of age, which was the highest age
for follow-up in this study. None of the post-epidemic birth
cohorts have had such a sharp increase in cumulative inci-
dence before 2 years of age, but have instead shown a grad-
ual increase as birth cohorts grow older (Figure 4).
The cumulative incidence of the post-epidemic birth
cohorts of 1995–1999 was significantly lower compared
to both the epidemic cohorts (1985–1994, p <0.001) and
the post-epidemic high-incidence cohorts of 2000–2002
(p <0.001). As the age of the birth cohorts increased, the
gap between the incidence of the epidemic birth cohorts
and that of the cohorts of 1995–1999 narrowed. The cu-
mulative incidence of the birth cohorts of 2000–2002
reached, and even exceeded, that of the epidemic co-
horts (1985–1994) during the last years of follow-up
when these cohorts were 6 to 9 years of age (Figure 4).
The birth cohorts of 2006–2008 diverged from other
post-epidemic birth cohorts by having the lowest cumula-
tive incidence up to 3 years of age ever reported since the
surveillance program started in 1973. The pre-epidemic
cohorts of 1973–1984 still had the lowest reported cumu-
lative incidence over the age span of 4 to 14 years of age.
Discussion
This study shows considerable changes in CD risk over
time in Sweden that are dependent on age and year ofbirth. Over the 36 years of follow-up we have observed
an overall increase in CD risk in the entire child popula-
tion except for a temporary decline from 1995 to 1997.
At the same time, a substantial drop in CD incidence
has occurred in the subgroup of children below 2 years
of age, with almost zero CD cases diagnosed within the
first year of life. The changing CD pattern is also illus-
trated by a continued increase in the median age at diag-
nosis. Our findings from cumulative incidence analysis
suggest that year of birth may determine specific CD
risks, exemplified by excess risk in the birth cohorts of
1985–1995 and 2000–2002. The observed fluctuations in
CD cannot be explained by genetic changes, and therefore
strongly suggest the role of cyclic environmental and life-
style risk factors in CD etiology.
The main strength of this study is the identification of
CD cases through the Swedish National Childhood CD
Register, with a prospective reporting since 1998 from
all pediatric departments in the country. Differences in
population coverage may not have introduced any major
biases, since our findings for the period from 1973 to
1990, with 15% coverage of the total child population are
comparable to findings from an earlier national wide study
conducted during the same period [13]. We have also pre-
viously shown that 40% coverage was sufficient for esti-
mating the national CD incidence [12].
In this study CD diagnosis was based on villous atro-
phy in order to avoid overestimation of the CD risk. We
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had elevated serological markers, minor enteropathy and
symptoms typical for CD. The observed overall increase
cannot by due to mass screening for the general population
since this has not been implemented in Sweden. Addition-
ally, serological testing in genetically susceptible high-risk
populations is encouraged and conducted liberally. How-
ever, this cannot be solely responsible for the observed
increase. The latest ESPGHAN guidelines where CD
diagnosis may be based on serological markers were in-
troduced in 2012 [14] and therefore did not influenced
our findings since our follow-up ended in 2009.
The limitation of this study is that the CD register pri-
marily captures cases detected clinically. However, it is
well established that most CD cases both worldwide and
in Sweden remain undiagnosed, and thus most CD stud-
ies and knowledge of CD are limited to clinical cases
[15,16]. In fact, our recent CD screening study revealed
two thirds of all cases were only identified through
screening [17].
We found an overall increase in CD incidence in chil-
dren mainly due to a rising incidence in children aged
2–14.9 years. An increase in CD occurrence [18-23] along
with other immune-mediated disorders such as diabetes,
asthma, and inflammatory bowel disease, is not unique to
Sweden and has been reported elsewhere [24-26]. In-
creased awareness may be one of the contributing factors
to the rising incidence observed in children aged 2–
14.9 years. However, this is insufficient in explaining varia-
tions seen in the youngest children in whom there has
been a sharp increase from 1985 to 1994, a sudden decline
from 1995 to 1997 and yet again a rapid increase from
2000 to 2002 followed by a persistent decline.
The median age at diagnosis has increased throughout
this follow-up; between 1973 and 1994 it was 1.2 years,
and rose to 6.7 years from 2004 to 2009. The upward
shift in age at diagnosis can partly be explained by the
fact that the epidemic birth cohorts of 1985–1995 are
getting older and are carrying along an excess risk. How-
ever we also notice a similar pattern in the post epidemic
birth cohorts thus suggesting additional exposures that
are probably related to modern life-styles and are yet to be
identified. Increased awareness of CD symptoms that are
typical in older children, as well as screening of siblings,
could have contributed to the shift towards an older age at
diagnosis, but the role of additional environmental factors
should not be overlooked.
The variations in incidence among children below 2 years
of age strongly suggest a role of environmental and/or life-
style exposures that change over time. We have previously
shown that infant feeding practices have played a crucial
role in the onset and the end of a 10-year Swedish CD epi-
demic during the mid 1980s up until 1995 [6,7]. The con-
tinuing drop in incidence among children below 2 years ofage began in 1995, coinciding with a one-third decrease in
the average daily consumption of gluten-containing flour
in children younger than 2 years of age, and introduction
of the new national infant feeding recommendation that
encouraged introduction of gluten in smaller amounts and
preferably from 4 months of age with continued breast-
feeding [6]. To date this recommendation remains in effect
and most likely contributes to the continued CD decline in
the youngest age group.
We previously showed a gap in the cumulative inci-
dence between the epidemic and post-epidemic cohorts,
but as both cohorts grow older, the gap continues to
narrow. This is true regardless of whether cases were
clinically detected or detected through screening [12,16].
In fact, during this follow-up, the cumulative incidence
of the post-epidemic cohorts of 2000–2002 has sur-
passed that of the epidemic birth cohort (1985–1995) at
certain ages. It is not yet clear as to why the 2000–2002
birth cohorts have a higher risk compared to other post-
epidemic cohorts, since infant feeding guidelines have
remained the same to date, thus stressing the role of
other yet unidentified environmental risk factors.
Other environmental and lifestyle factors such as an
increase in gluten consumption may explain the observed
changes including the gradual increase seen over time
among children 2–14.9 years, but can hardly explain the
shorter and sudden changes that have been observed, es-
pecially in children below 2 years of age. The variations in
the youngest children seemed to have an epidemic pattern
both in period from 1985 to 1995 and the period from
2000 to 2002 and therefore are more likely to be associ-
ated with periodical changes such as episodes of infections
[8,27,28]. Interestingly, during the Swedish CD epidemic,
rod-shaped bacteria were often found in the small intes-
tinal mucosa of children with CD, but not in controls, and
rarely in biopsies from later periods [29]. Changes in the
intestinal microbiota have also been associated with CD
susceptibility and might play a role in explaining our ob-
servations [30-32].
Another crucial factor that needs to be examined is
whether the observed CD increase is due to increasing
immigration. Sweden, just like other European countries,
has experienced a positive trend of net migration from
abroad. Nevertheless, it is unlikely that the demonstrated
CD increase is due to increasing immigration, because the
majority of the immigrant population comes from low CD-
prevalent countries. During the 1980s, immigration was
mainly from Iran, Lebanon, Poland and Turkey. In the
1990s immigration was mainly from the former Yugoslavia,
and in the 2000s from Iraq, Somalia, Afghanistan and
Ethiopia [33]. Moreover, a recent study of worldwide im-
migration in Sweden showed non-European ethnicities to
have a much lower CD susceptibility compared to the na-
tive population [34].
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In conclusion, this study demonstrates a significant rise
in the incidence of childhood CD from 1973 to 2009.
From following the child population of CD in Sweden
for 36 years we have learned that CD incidence seems to
be heavily influenced by changes in the environment and
lifestyles. This implies that CD research should prioritize
identification of new environmental agents that could
contribute to new preventive strategies in addition to in-
fant feeding, which is already implemented in both Europe
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